Pimecrolimus
9 NDCs across 3 manufacturers|9 Generic,0 Brand
Pimecrolimus is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 13, 2001, and the first generic was approved Dec 27, 2018. FDA's Orange Book lists 3 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $17 million on Pimecrolimus across 71,000 claims for 42,000 beneficiaries.
Pimecrolimus is available as 9 NDCs from 3 manufacturers (9 generic, 0 brand), with NADAC prices from $2.49 to $3.39 per GM — a 36% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
3
competing in market
Price Spread
$2.49 – $3.39
per GM
7d Activity
avg -0.2% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Calcineurin Inhibitor Immunosuppressant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing PIMECROLIMUS
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PIMECROLIMUS 1% CREAM | $3.3861 per GM | +4.05% |
PIMECROLIMUS 1% CREAM | $3.3861 per GM | +4.05% |
PIMECROLIMUS 1% CREAM | $3.3149 per GM | -2.00% |
PIMECROLIMUS 1% CREAM | $3.3149 per GM | -2.00% |
PIMECROLIMUS 1% CREAM | $3.1701 per GM | — |
PIMECROLIMUS 1% CREAM | $3.1048 per GM | -2.68% |
PIMECROLIMUS 1% CREAM | $3.1048 per GM | -2.68% |
PIMECROLIMUS 1% CREAM | $2.7187 per GM | — |
PIMECROLIMUS 1% CREAM | $2.4853 per GM | — |
Frequently Asked Questions
What is Pimecrolimus used to treat?
Pimecrolimus is used to treat atopic dermatitis, per the National Library of Medicine's MED-RT classification.
When did Pimecrolimus become available as a generic?
FDA approved the first generic Pimecrolimus (ANDA) on Dec 27, 2018. The Orange Book currently lists 3 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Pimecrolimus?
In 2024, Medicare Part D spent $17 million on Pimecrolimus across 71,000 claims for 42,000 beneficiaries.
How many Pimecrolimus products are on the market?
The Pimecrolimus drug market contains 9 NDCs from 3 manufacturers — 9 generic and 0 brand products.
What is the price range for Pimecrolimus?
NADAC reference prices for Pimecrolimus range from $2.4853 to $3.3861 per GM — a 36% difference between cheapest and most expensive.
Which manufacturers make Pimecrolimus?
3 manufacturers list Pimecrolimus in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (3), Actavis Pharma, Inc. (3), Oceanside Pharmaceuticals (3).
How has the price of Pimecrolimus changed recently?
Over the past 7 days, 2 Pimecrolimus NDCs rose and 4 fell, with a market-wide average change of -0.2%.